We are live on ! Find out more
OPU

Omni Partners US Portfolio holdings

AUM $1.95B
This Fund
S&P 500
This Quarter Est. Return
+13.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.27B
AUM Growth
–
Cap. Flow
+$2.08B
Cap. Flow %
91.71%
Top 10 Hldgs %
60.91%
Holding
226
New
226
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$220M
2
MXIM
Maxim Integrated Products
MXIM
+$217M
3
XLNX
Xilinx Inc
XLNX
+$177M
4
NUAN
Nuance Communications, Inc.
NUAN
+$119M
5
WORK
Slack Technologies, Inc.
WORK
+$108M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 20.95%
2 Healthcare 18.72%
3 Financials 17.48%
4 Consumer Discretionary 8.17%
5 Communication Services 4.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSTA
101
DELISTED
Constellation Acquisition Corp I
CSTA
$2.24M 0.1%
+228,806
New +$2.24M
LVRA
102
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
$2.24M 0.1%
+228,787
New +$2.24M
SLCR
103
DELISTED
Silver Crest Acquisition Corporation Class A Ordinary Share
SLCR
$2.22M 0.1%
+229,979
New +$2.23M
EPWR
104
DELISTED
Empowerment & Inclusion Capital I Corp.
EPWR
$2.21M 0.1%
+226,170
New +$2.2M
ENJY
105
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
$2.19M 0.1%
+221,220
New +$2.19M
CONX
106
DELISTED
CONX Corp. Class A Common Stock
CONX
$2.18M 0.1%
+220,891
New +$2.19M
TWLV
107
DELISTED
Twelve Seas Investment Company II Class A Common Stock
TWLV
$2.15M 0.09%
+222,915
New +$2.16M
TLSI icon
108
TriSalus Life Sciences
TLSI
$267M
$2.14M 0.09%
+220,971
New +$2.17M
PUCK
109
DELISTED
Goal Acquisitions Corp. Common Stock
PUCK
$2.12M 0.09%
+219,503
New +$2.12M
ACIC
110
DELISTED
Atlas Crest Investment Corp.
ACIC
$2.08M 0.09%
+208,597
New +$2.08M
BOAS
111
DELISTED
BOA Acquisition Corp.
BOAS
$2.08M 0.09%
+214,654
New +$2.09M
SWET
112
DELISTED
Athlon Acquisition Corp. Class A Common stock
SWET
$2.07M 0.09%
+214,731
New +$2.08M
CELU icon
113
Celularity
CELU
$21.7M
$2.07M 0.09%
+20,345
New +$2.06M
EQHA
114
DELISTED
EQ Health Acquisition Corp.
EQHA
$2.05M 0.09%
+211,812
New +$2.07M
PNTM
115
DELISTED
Pontem Corporation
PNTM
$2.04M 0.09%
+210,397
New +$2.05M
ML
116
DELISTED
MoneyLion Inc.
ML
$2.04M 0.09%
+6,827
New +$2.03M
PIII icon
117
P3 Health Partners
PIII
$35.2M
$2.04M 0.09%
+4,118
New +$2.02M
HUMA icon
118
Humacyte
HUMA
$167M
$1.96M 0.09%
+191,925
New +$1.98M
HERA
119
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
$1.92M 0.08%
+197,195
New +$1.93M
LJAQ
120
DELISTED
LightJump Acquisition Corporation Common Stock
LJAQ
$1.92M 0.08%
+196,591
New +$1.93M
BNAI
121
Brand Engagement Network
BNAI
$77.9M
$1.9M 0.08%
+19,560
New +$1.9M
DSAC
122
DELISTED
Duddell Street Acquisition Corp. Class A Ordinary Shares
DSAC
$1.89M 0.08%
+195,486
New +$1.92M
USAS
123
Americas Gold and Silver
USAS
$1.25B
$1.84M 0.08%
+73,756
New +$360K
MON
124
DELISTED
Monument Circle Acquisition Corp. Class A Common Stock
MON
$1.82M 0.08%
+188,396
New +$1.84M
HCCC
125
DELISTED
Healthcare Capital Corp. Class A common stock
HCCC
$1.82M 0.08%
+188,595
New +$1.83M
3 4
5
6 7

Similar funds

XEA
XN Exponent Advisors New York $2.09B AUM 32.83% 1-Year Est. Return
AIC
Ameritas Investment Company Lincoln, Nebraska $2.17B AUM 26.5% 1-Year Est. Return
QAM
QCI Asset Management Pittsford, New York $1.72B AUM 25.41% 1-Year Est. Return
BU
BBVA USA Birmingham, Alabama $1.71B AUM
H
Hexavest Montreal, Quebec, Canada $1.64B AUM 28.34% 1-Year Est. Return
FMW
Farr Miller & Washington Washington, District of Columbia $1.53B AUM 32.74% 1-Year Est. Return
MAFM
Mid Atlantic Financial Management Pittsburgh, Pennsylvania $1.49B AUM 24.08% 1-Year Est. Return
BOS
Bingham Osborn & Scarborough San Francisco, California $1.42B AUM 27.88% 1-Year Est. Return

Omni Partners US's Q2 2021 Portfolio in Review

Q2 2021 is the first quarter with a 13F filing on record for Omni Partners US, which disclosed 226 positions worth $2.27B. Its ten largest holdings account for 61% of the portfolio.

Its largest position is Alexion Pharmaceuticals: 1,283,115 shares worth $326M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, followed by Healthcare and Financials.

  • Omni Partners US's largest Q2 2021 buy was Alexion Pharmaceuticals: 1,283,115 shares worth $326M.
  • Omni Partners US's ten largest holdings make up 61% of its $2.27B portfolio in Q2 2021.
  • Omni Partners US disclosed 226 positions in Q2 2021, its first 13F filing on record.

Based on Omni Partners US's 13F filing for Q2 2021, filed 16 Aug 2021.